Identification of Potential Biomarkers of Peptide Immunotherapy. Part 1 - Proteomics Analysis
NCT01383590
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
10
Enrollment
INDUSTRY
Sponsor class
Conditions
Cat Allergy
Interventions
BIOLOGICAL:
Cat-PAD
Sponsor
Circassia Limited
Collaborators
[object Object]